Table 3.

Risk prediction models for PTS

SOX-PTS score34 PointsAmin et al35 PointsMéan et al36 Points
Age, y —  >56 ≥75 
BMI, kg/m2 ≥35 >30 —  
DVT anatomy Iliac DVT Iliofemoral DVT Multilevel thrombosis 
Signs of preexisting venous insufficiency Baseline Vilalta score  Varicose veins Prior varicose vein surgery 
>14 (severe) 
10-14 (moderate) 
      N of leg signs and symptoms* 1 (for each) 
Other —  Smoking Concomitant antiplatelet/NSAID therapy 
    Female sex   
    Provoked DVT   
    History of DVT   
Risk category Total score PTS risk, % Total score PTS risk, % Total score PTS risk, % 
Low 6.4 0-2 10 0-3 24.4 
  13.4     
Intermediate 16.4 3-4 20 4-5 38.4 
  25     
High ≥4 30 ≥5 40 ≥6 80.7 
SOX-PTS score34 PointsAmin et al35 PointsMéan et al36 Points
Age, y —  >56 ≥75 
BMI, kg/m2 ≥35 >30 —  
DVT anatomy Iliac DVT Iliofemoral DVT Multilevel thrombosis 
Signs of preexisting venous insufficiency Baseline Vilalta score  Varicose veins Prior varicose vein surgery 
>14 (severe) 
10-14 (moderate) 
      N of leg signs and symptoms* 1 (for each) 
Other —  Smoking Concomitant antiplatelet/NSAID therapy 
    Female sex   
    Provoked DVT   
    History of DVT   
Risk category Total score PTS risk, % Total score PTS risk, % Total score PTS risk, % 
Low 6.4 0-2 10 0-3 24.4 
  13.4     
Intermediate 16.4 3-4 20 4-5 38.4 
  25     
High ≥4 30 ≥5 40 ≥6 80.7 

BMI, body mass index; NSAID, nonsteroidal antiinflammatory drug.

*

Pain, cramps, heaviness, pruritus, paraesthesias, edema, skin induration, hyperpigmentation, venous ectasia, redness, and pain during calf compression.

Close Modal

or Create an Account

Close Modal
Close Modal